by Charles Curry Jr and Noel McElreath | Apr 26, 2021 | Xponance® Insights
The start to 2021 was among the worst for the broad bond market, and its constituent sectors, in quite a long while. To put this in historical perspective, first quarter 2021 was the 4th worst total return for the Bloomberg Barclay’s Aggregate since …
by Sumali Sanyal and Cameron McLennan | Apr 21, 2021 | Xponance® Insights
The year started out on an uncertain note with protestors storming the United States Capitol, emergence of new virus mutations, the uneven distribution of COVID-19 vaccines, and unusual, highly targeted trading activity and stock price manipulation from retail investors involving several companies.
by Thomas Quinn and Bin Cheng | Apr 19, 2021 | Xponance® Insights
Over the past decade, our research has taken multiple in-depth looks at the exogenous drivers of what we think of as “alpha availability” among active managers.
by Adam Choppin | Mar 25, 2021 | Xponance® Insights
In a market filled with liquidity and searching eagerly for the next growth story, electric vehicle (EV) companies, and their supply chain are seeing a lot of flows. Most famously, Tesla shot up 7x in 2020 after finally turning a profit for the first time in its history.
by Adam Choppin | Feb 10, 2021 | Xponance® Insights
The best performing emerging market of the past decade gets no love from investors. Taiwan is a perennial underweight for active global emerging market (GEM) funds, despite being the best performing market over the past decade.
by Sumali Sanyal and Cameron McLennan | Feb 1, 2021 | Xponance® Insights
Although equity markets have been steadily rising, quantitative strategies have found it challenging to beat broad market indices, especially for the past three years. A number of macro catalysts, most notably, the ongoing coronavirus pandemic, have created …